Wang Yaru, Shang Yunxia, Tang Fengyu, Qiu Kun, Wei Xiaohui, Wang Zhengtao
The MOE Key Laboratory for Standardization of Chinese Medicines and the SHTCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201210, China.
Shanghai R&D Center for Standardization of Chinese Medicines, Shanghai, 201210, China.
AAPS PharmSciTech. 2023 Mar 28;24(4):90. doi: 10.1208/s12249-023-02549-0.
In this work, self-double-emulsifying drug delivery system enteric-coated capsules (PNS-SDE-ECC) were used to enhance the oral bioavailability and anti-inflammatory effects of Panax notoginseng saponins (PNS), which are rapidly biodegradable, poorly membrane permeable, and highly water-soluble compounds. The PNS-SDEDDS formulated by a modified two-step method spontaneously emulsified to W/O/W double emulsions in the outer aqueous solution, which significantly promoted the absorption of PNS in the intestinal tract. The release study revealed that PNS-SDE-ECC exhibited sustained release of PNS within 24 h and the stability study indicated that PNS-SDE-ECC were stable at room temperature for up to 3 months. Furthermore, compared to PNS gastric capsules, the relative bioavailability of NGR1, GRg1, GRe, GRb1, and GRd in PNS-SDE-ECC was increased by 4.83, 10.78, 9.25, 3.58, and 4.63 times, respectively. More importantly, PNS-SDE-ECC significantly reduced OXZ-induced inflammatory damage in the colon by regulating the expression of TNF-α, IL-4, IL-13, and MPO cytokines. Overall, the prepared PNS-SDE-ECC may serve as a viable vehicle for increasing the oral bioavailability of PNS and its anti-inflammatory action on ulcerative colitis.
在本研究中,采用自乳化双相释药系统肠溶胶囊(PNS-SDE-ECC)来提高三七总皂苷(PNS)的口服生物利用度和抗炎作用,三七总皂苷是一类可快速生物降解、膜通透性差且水溶性高的化合物。通过改良的两步法制备的PNS-SDEDDS在外部水溶液中自发乳化形成W/O/W型复乳,显著促进了PNS在肠道的吸收。释放研究表明,PNS-SDE-ECC在24小时内呈现PNS的缓释特性,稳定性研究表明PNS-SDE-ECC在室温下可稳定保存长达3个月。此外,与PNS胃溶胶囊相比,PNS-SDE-ECC中NGR1、GRg1、GRe、GRb1和GRd的相对生物利用度分别提高了4.83倍、10.78倍、9.25倍、3.58倍和4.63倍。更重要的是,PNS-SDE-ECC通过调节TNF-α、IL-4、IL-13和MPO细胞因子的表达,显著减轻了OXZ诱导的结肠炎症损伤。总体而言,所制备的PNS-SDE-ECC可作为一种可行的载体,用于提高PNS的口服生物利用度及其对溃疡性结肠炎的抗炎作用。